Anurag Singh, MD

Articles by Anurag Singh, MD

Updated Data Confirm Benefit of Single SBRT Dose for NSCLC

March 20th 2017

This video examines updated data from a phase II trial that compared a single dose of high-intensity SBRT with a standard three-dose schedule as treatment for patients with non-small-cell lung cancer.

Latest Updated Articles

Updated Data Confirm Benefit of Single SBRT Dose for NSCLC
Published: March 20th 2017 | Updated:

Anurag Singh, MD

Articles by Anurag Singh, MD

Updated Data Confirm Benefit of Single SBRT Dose for NSCLC

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Revumenib in R/R NPM1-Mutant AML

FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma

Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment

FDA Grants Fast Track Designation to MT-125 in Glioblastoma

FDA Grants BTD to Zenocutuzumab in NRG1+ Cholangiocarcinoma